IP Library Granted Patent US 9,499,854
Granted Patent B2
US 9,499,854 · App. 13/761,968 · Granted Nov 22, 2016

Tyrosine kinase biosensors and methods of use

Inventors: Laurie Louise Parker (Minneapolis, MN); Andrew M. Lipchik (Palo Alto, CA); Scott Charles Bolton (West Lafayette, IN)
Assignee: Purdue Research Foundation
C12Q1/485
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,499,854
App. No.
13/761,968
Granted
Nov 22, 2016
Kind
B2
Abstract

The claims describe a process for designing and validating peptide-based substrates for a specified kinase. The process uses a rational approach to design peptides with a specific amino acid that is phosphorylated by a target tyrosine kinase, and upon phosphorylation shows an increased affinity for a lanthanide ion that results in an enhanced fluorescent signal. The process uses kinase specific input data sets, encodes the input into positional scoring matrices, analyses the positional scoring matrices in order to generate a candidate list of peptide sequences, compares the peptide sequences in the candidate list, substitutes residues at non-selective positions in selections from the candidate list with terbium binding residues, and then screens the substituted selections with different kinases in vitro.

Claims (24)

1. A method for designing peptide substrates phosphorylated by a single target kinase family which, upon phosphorylation, binds and enhances lanthanide ion sensitization, binding affinity and luminescent lifetime without the need for sensitizing agents, the method comprising:

(a) curating kinase specific input data sets consisting of validated endogenous sequences for peptide substrates and the target kinase family interacting partner sequences;

(b) encoding the input data sets from step (a) into positional scoring matrices;

(c) manipulating the positional scoring matrices generated in step (b) to identify positions required for kinase selectivity, scoring amino acids overrepresented 4 residues upstream and downstream of a phosphorylated residue;

(d) generating a candidate list of peptide sequences based on combinatorial peptide sequences of a result in step (c);

(e) comparing the combinatorial peptide sequences of step (d) to the combinatorial peptide sequences for at least one other kinase;

(f) using the results of steps (c)-(e), substitute residues at non-selective positions in selections from the candidate list of peptide sequences from step (e) with terbium binding residues by comparing sequence similarity scores to a known terbium binding motif; and

(g) screening the selections from the candidate list of peptide sequences with substituted residues from step (f) in vitro for the ability to bind terbium in a phosphorylation dependent manner.

2. The method of claim 1 , wherein the peptide substrate is a substrate for a tyrosine kinase.

3. The method of claim 1 , wherein the peptide substrate is a substrate for a serine/threonine kinase.

4. The method of claim 2 , wherein the tyrosine kinase is selected from the group consisting of Abl, Arg, Btk, Csk, Fyn, Hck, Jak2, Lck, Lyn, Pyk2, Src, Syk, and Yes.

5. The method of claim 4 , wherein the tyrosine kinase is Abl.

6. The method of claim 4 , wherein the tyrosine kinase is Arg.

7. The method of claim 4 , wherein the tyrosine kinase is Btk.

8. The method of claim 4 , wherein the tyrosine kinase is Csk.

9. The method of claim 4 , wherein the tyrosine kinase is Fyn.

10. The method of claim 4 , wherein the tyrosine kinase is Jak2.

11. The method of claim 4 , wherein the tyrosine kinase is Lck.

12. The method of claim 4 , wherein the tyrosine kinase is Lyn.

13. The method of claim 4 , wherein the tyrosine kinase is Pyk2.

14. The method of claim 4 , wherein the tyrosine kinase is Src.

15. The method of claim 4 , wherein the tyrosine kinase is Syk.

16. The method of claim 4 , wherein the tyrosine kinase is Hck.

17. The method of claim 4 , wherein the tyrosine kinase is Yes.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 19, 2013
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030657/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2013
From: PARKER, LAURIE LOUISE; LIPCHIK, ANDREW MICHAEL; BOLTON, SCOTT CHARLES
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 030425/0852 →
Continuity (8)
Provisional Application 61595959 · Feb 7, 2012
Provisional Application 61603752 · Feb 27, 2012
Provisional Application 61605591 · Mar 1, 2012
Provisional Application 61693002 · Aug 24, 2012
Provisional Application 61704298 · Sep 21, 2012
Provisional Application 61736312 · Dec 12, 2012
Provisional Application 61721938 · Nov 2, 2012
Related Publication 20130231265A1 · Sep 5, 2013